Catalyst Wire Dossier Catalyst Wire Dossier

Dexborneol Sublingual Tablet

dexborneol
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dexborneol Sublingual Tablet, covering 2026-03-06 to 2026-03-06. Get the full timeline:

Most recent: Clinical Trial Update: Edaravone and Dexborneol Sublingual Tablet for Treating Chemotherapy- Induced Cognitive Impairment Study [Phase 4]

See pricing